Back to top
more

Pfizer (PFE)

(Real Time Quote from BATS)

$28.47 USD

28.47
11,702,395

-0.05 (-0.18%)

Updated Oct 31, 2024 01:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (53 out of 251)

Industry: Large Cap Pharmaceuticals

Better trading starts here.

Zacks News

Urmimala Biswas headshot

3 Growth Stocks to Tap the COVID-Driven Shift in MedTech

To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.

Kinjel Shah headshot

Pharma Stock Roundup: Approval of PFE/BNTX Coronavirus Vaccine in UK, Other Updates

Pfizer (PFE) COVID-19 vaccine gets approval for emergency use in the United Kingdom while Roche's (RHHBY) Xolair gets FDA nod for new indication.

Nalak Das headshot

5 Mid-Cap Stocks That Became Top Large Caps Amid Pandemic

We have narrowed our search to five mid-cap stocks that have become large caps during the coronavirus hit past eight and a half months. These are: SAM, LB, PKI, UI, GNRC.

Sheraz Mian headshot

Top Analyst Reports for Cisco, CVS Health & Moderna

Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), CVS Health Corporation (CVS) and Moderna, Inc. (MRNA).

John Blank headshot

The Vaccines Are Here. Are We Out of the Woods Now?

It almost seems like we are just an appointment at the doctor's office away from opening up our economy again.

Pfizer (PFE) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $40.09, marking a -1.74% move from the previous day.

Goldman Sachs, Hexcel Corp, Pfizer, CrowdStrike and Snowflake highlighted as Zacks Bull and Bear of the Day

Goldman Sachs, Hexcel Corp, Pfizer, CrowdStrike and Snowflake highlighted as Zacks Bull and Bear of the Day

Stock Market News for Dec 3, 2020

U.S. stock markets closed modestly higher on Wednesday as investors await fresh round of fiscal stimulus.

Sweta Killa headshot

Stocks to Track in December as Markets Peak

December is likely to be filled with events or stock/sector specific news that could provide a boost to the stocks.

3 Biotech Stocks to Buy on First Vaccine Approval Optimism

Here we discuss three potential stocks that can gain following mass availability of vaccine. Vaccination may release pent-up demand across sectors. It will also help biotechs progress with their clinical studies without any disruption.

Nalak Das headshot

5 Stocks to Buy at Deep Discount for a Stronger Portfolio

Discounted stock price and a favorable Zacks Rank will be the right combination to strengthen one's portfolio in the near future. These stocks include PHM, LEN, SAM, W, DT.

Nilanjan Choudhury headshot

Oil Ends Higher on Vaccine News Despite EIA's Bearish Report

The top five gainers of the S&P 500 in November were all energy firms - Occidental Petroleum (OXY), Devon Energy (DVN), Apache (APA), Diamondback Energy (FANG) and TechnipFMC (FTI).

Mark Vickery headshot

CrowdStrike (CRWD) Beats, Snowflake (SNOW) Mixed in Q3

Cyberintelligence security firm CrowdStrike surged well ahead of estimates on every metric in its Q3 report, while fledgling enterprise software firm Snowflake missed on its bottom line.

Sweta Jaiswal, FRM headshot

Pfizer's Coronavirus Vaccine Gets a Nod in UK: ETFs to Shine

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

Biotech Stock Roundup: BIIB & SAGE Alliance, MRNA, BNTX Coronavirus Updates & More

Collaborations, and pipeline and regulatory updates take centerstage in the biotech sector as Moderna (MRNA) and BioNTech (BNTX) provide key updates.

Sweta Killa headshot

After a Historic November, What Awaits ETFs in December?

Let's delve into some of the major events of December and learn how to tap the opportune moments with ETFs.

Pfizer/BioNTech's COVID-19 Vaccine Gets Approval in U.K.

Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate becomes the first-ever vaccine to get authorization.

Encouraging News on COVID-19 Vaccine

Encouraging News on COVID-19 Vaccine

Mark Vickery headshot

ADP Reports 307K New Jobs, Revisions Up

307K new private-sector jobs was lower than expected, and beneath the upwardly revised 404K from October.

Sweta Killa headshot

5 International ETFs That Outstripped US Market in November

November was a banner month for the global stock market despite the rising number of COVID-19 cases.

Cimarex Energy (XEC) Up 48.6% QTD: What's Behind the Rally?

Improving oil prices on positive coronavirus vaccine results aid Cimarex (XEC).

Stock Market News for Dec 2, 2020

U.S. stock markets closed higher on Tuesday on the back of optimism surrounding COVID-19 vaccine.

Pfizer/BioNTech Seek Marketing Nod for COVID-19 Vaccine in EU

Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is 95% effective in final analysis.

Kinjel Shah headshot

Will Americans Get COVID-19 Vaccine Sooner Than Europeans?

Moderna (MRNA), and Pfizer (PFE)/BioNTech (BNTX) file for emergency use authorization of their COVID-19 vaccine candidates in Europe

Neena Mishra headshot

Small Cap ETFs Deliver Big Gains for Investors

November was the best month ever for the Russell 2000 index